Search research articles
Contact Us
Filters
Showing results (71-80 of 84) with videos related to
Page
of 9
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
February 11, 1998
Integration of filgrastim into chemoradiation for limited small cell lung cancer: a Phase I study
B Glisson, R Komaki, J S Lee, et al.
Blood
|
October 1, 1989
Stimulation of nonclonal hematopoiesis and suppression of the neoplastic clone after treatment with recombinant human granulocyte-macrophage colony-stimulating factor in a patient with therapy-related myelodysplastic syndrome
S Vadhan-Raj, H E Broxmeyer, G Spitzer, et al.
The New England Journal of Medicine
|
December 22, 1988
Stimulation of myelopoiesis in patients with aplastic anemia by recombinant human granulocyte-macrophage colony-stimulating factor
S Vadhan-Raj, S Buescher, H E Broxmeyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1988
Phase I trial of a mouse monoclonal antibody against GD3 ganglioside in patients with melanoma: induction of inflammatory responses at tumor sites
S Vadhan-Raj, C Cordon-Cardo, E Carswell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 11, 1992
Abrogating chemotherapy-induced myelosuppression by recombinant granulocyte-macrophage colony-stimulating factor in patients with sarcoma: protection at the progenitor cell level
S Vadhan-Raj, H E Broxmeyer, W N Hittelman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1994
Effects of PIXY321, a granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein, on chemotherapy-induced multilineage myelosuppression in patients with sarcoma
S Vadhan-Raj, N E Papadopoulos, M A Burgess, et al.
Blood Cancer Journal
|
January 9, 2016
Evaluating results from the multiple myeloma patient subset treated with denosumab or zoledronic acid in a randomized phase 3 trial
N Raje, S Vadhan-Raj, W Willenbacher, et al.
Annals of Internal Medicine
|
February 26, 2000
Recombinant human thrombopoietin attenuates carboplatin-induced severe thrombocytopenia and the need for platelet transfusions in patients with gynecologic cancer
S Vadhan-Raj, C F Verschraegen, C Bueso-Ramos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 2, 2012
Clinical benefit in patients with metastatic bone disease: results of a phase 3 study of denosumab versus zoledronic acid
S Vadhan-Raj, R von Moos, L J Fallowfield, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 24, 2015
Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristics
A Lipton, K Fizazi, A T Stopeck, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 84) with videos related to
Sort By:
Page
of 9
International Journal of Radiation Oncology, Biology, Physics
|
February 11, 1998
Integration of filgrastim into chemoradiation for limited small cell lung cancer: a Phase I study
B Glisson, R Komaki, J S Lee, et al.
Blood
|
October 1, 1989
Stimulation of nonclonal hematopoiesis and suppression of the neoplastic clone after treatment with recombinant human granulocyte-macrophage colony-stimulating factor in a patient with therapy-related myelodysplastic syndrome
S Vadhan-Raj, H E Broxmeyer, G Spitzer, et al.
The New England Journal of Medicine
|
December 22, 1988
Stimulation of myelopoiesis in patients with aplastic anemia by recombinant human granulocyte-macrophage colony-stimulating factor
S Vadhan-Raj, S Buescher, H E Broxmeyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1988
Phase I trial of a mouse monoclonal antibody against GD3 ganglioside in patients with melanoma: induction of inflammatory responses at tumor sites
S Vadhan-Raj, C Cordon-Cardo, E Carswell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 11, 1992
Abrogating chemotherapy-induced myelosuppression by recombinant granulocyte-macrophage colony-stimulating factor in patients with sarcoma: protection at the progenitor cell level
S Vadhan-Raj, H E Broxmeyer, W N Hittelman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1994
Effects of PIXY321, a granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein, on chemotherapy-induced multilineage myelosuppression in patients with sarcoma
S Vadhan-Raj, N E Papadopoulos, M A Burgess, et al.
Blood Cancer Journal
|
January 9, 2016
Evaluating results from the multiple myeloma patient subset treated with denosumab or zoledronic acid in a randomized phase 3 trial
N Raje, S Vadhan-Raj, W Willenbacher, et al.
Annals of Internal Medicine
|
February 26, 2000
Recombinant human thrombopoietin attenuates carboplatin-induced severe thrombocytopenia and the need for platelet transfusions in patients with gynecologic cancer
S Vadhan-Raj, C F Verschraegen, C Bueso-Ramos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 2, 2012
Clinical benefit in patients with metastatic bone disease: results of a phase 3 study of denosumab versus zoledronic acid
S Vadhan-Raj, R von Moos, L J Fallowfield, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 24, 2015
Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristics
A Lipton, K Fizazi, A T Stopeck, et al.
Page
of 9